|
|
Gilbert MR, Gonzalez J, Hunter K, Hess K, Giglio P, Chang E, Puduvalli V,
Groves MD, Colman H, Conrad C, Levin V, Woo S, Mahajan A, de Groot J, Yung
WK.
A
phase I factorial design study of dose-dense temozolomide alone and
in combination with thalidomide, isotretinoin, and/or celecoxib as
postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
Neuro Oncol. 2010 Nov;12(11):1167-72.
Epub 2010 Aug 20.
.JPG)
Abstract |
.png)
Reprint |
.gif)
Related articles
|
